Hydrogel-based senomorphic approaches to modulate cellular senescence and promote tissue rejuvenation.
Key claim: Hydrogel systems can integrate material-intrinsic bioactivity with localized, sustained delivery of senomorphic cargos to attenuate cellular senescence and support tissue rejuvenation while preserving resident cells in low-regenerative tissues.
Abstract
Cellular senescence is a major driver of age-related tissue dysfunction, characterized by chronic inflammation, oxidative stress, mitochondrial impairment, and disrupted extracellular matrix homeostasis. While senolytic strategies that eliminate senescent cells have shown therapeutic promise, irreversible cell loss may be detrimental in tissues with limited regenerative capacity. As a result, increasing attention has shifted toward senomorphic and microenvironment-modulating approaches that attenuate senescent phenotypes while preserving resident cells. However, many senescence-modulating agents are limited by poor solubility, spatial localization and rapid tissue clearance. Hydrogels have emerged as powerful platforms to address these challenges by enabling localized and sustained delivery of senescence-modulating cargos. Beyond serving as passive carriers, hydrogels can be engineered with intrinsic bioactivity and tunable biochemical and physical properties that regulate oxidative stress, inflammatory signaling, and cell-matrix interactions within aged or degenerative tissues. This review summarizes recent advances that demonstrate how hydrogel design can synergistically integrate material-driven rejuvenation with controlled delivery of senomorphic cargos, support multimodal therapeutic strategies, and create defined cellular niches that modulate senescence. Collectively, these developments position hydrogel-based systems as an integrative and versatile framework for spatially precise, mechanism-driven modulation of senescence and age-associated tissue dysfunction.
Why this matters
Most senotherapy translation efforts stall on systemic dosing tradeoffs — off-target toxicity of senolytics and the difficulty of sustaining senomorphic exposure at a target tissue. Framing hydrogels as dual-function platforms (intrinsic bioactivity plus depot delivery) positions the delivery vehicle itself as part of the mechanism rather than a passive carrier, particularly for tissues where cell-killing senolysis is undesirable. This is a materials-science synthesis and not a new efficacy signal; whether these platforms outperform free-drug senomorphics in mammalian healthspan endpoints is untested.